Back
MiNK Therapeutics 10K Form
Sell
46
INKT
MiNK Therapeutics
Last Price:
$26.20
Seasonality Move:
1.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INKT News And Ratings
See the #1 stock for the next 7 days that we like better than INKT
INKT Financial Statistics
Sales & Book Value
| Annual Sales: | $689.6K |
|---|---|
| Cash Flow: | $-1.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-5.50 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.56000 |
|---|---|
| Net Income (TTM): | $-9.7M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
MiNK Therapeutics Earnings Forecast
Key MiNK Therapeutics Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 4 years.
MiNK Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INKT |
| Website: | minktherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INKT Technical Analysis vs Fundamental Analysis
Sell
46
MiNK Therapeutics (INKT)
is a Sell
Is MiNK Therapeutics a Buy or a Sell?
-
MiNK Therapeutics stock is rated a SellThe current MiNK Therapeutics [INKT] share price is $23.11. The Score for INKT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.